News Search

Law firm Osborne Clarke has joined the MAIN Partner Community

The MAIN Partner Community is a community created for technology integrators, IT experts and providers of services that fit into...

Published on 14/09/2023

Osborne Clarke advises Kester Capital on its sixth Life Sciences services deal

Osborne Clarke has advised UK private equity firm Kester Capital on its investment in GXP Engaged. GXP Engaged is a...

Published on 14/09/2023

Osborne Clarke recognized in IFLR1000 ranking

Osborne Clarke law firm was recognized in the IFLR1000 international ranking in two categories: 1) M&A and 2) Project finance...

Published on 13/09/2023

Osborne Clarke advises Appmatics on investment by Hannover Finanz

Osborne Clarke has advised web and app testing provider Appmatics on Hannover Finanz's entry with a minority stake of 40...

Published on 13/09/2023

Osborne Clarke and Adacta Tax & Legal advise Georg Fischer and Salvagnini Italia in a minority investment in Tecnolaser S.r.l.

Georg Fischer Holding S.r.l., a company belonging to the Swiss industrial conglomerate Georg Fischer, active in the field of industrial...

Published on 13/09/2023

Osborne Clarke advises Kester Capital on its sixth Life Sciences services deal

Kester Capital, the UK lower mid-market private equity specialist, has announced its investment in GXP Engaged, a leading provider of...

Published on 13/09/2023

Read time 1m

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

Law firm Osborne Clarke has joined the MAIN Partner Community

Osborne Clarke advises Kester Capital on its sixth Life Sciences services deal

Osborne Clarke recognized in IFLR1000 ranking

Osborne Clarke advises Appmatics on investment by Hannover Finanz

Osborne Clarke and Adacta Tax & Legal advise Georg Fischer and Salvagnini Italia in a minority investment in Tecnolaser S.r.l.

Osborne Clarke advises Kester Capital on its sixth Life Sciences services deal

Sign up for our newsletter

Legal Notice